EVA1A and metabolic dysfunction-associated steatotic liver disease: These findings verified that EVA1A regulates crucial factors engaged in fatty acid uptake, such as CD36, through the mTORC1–PPARγ2 pathway, thereby influencing fatty acid uptake and lipid droplet accumulation, which affects MASLD onset and progression.